Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
Data up to Jan 2025
Total Citations Per Year
Abstract
References (35)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 • 25,662 citations
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 • 3,396 citations
The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
2004 • 2,991 citations
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
2002 • 1,778 citations
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
2002 • 1,556 citations
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
2008 • 1,539 citations
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
2006 • 1,440 citations
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
2008 • 1,098 citations
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
2003 • 930 citations
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
2006 • 890 citations
[Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59].
2008 • 624 citations
Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure
2004 • 599 citations
Effects of a Short-Term Vitamin D3 and Calcium Supplementation on Blood Pressure and Parathyroid Hormone Levels in Elderly Women1
2001 • 596 citations
Avosentan for Overt Diabetic Nephropathy
2010 • 454 citations
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
2005 • 371 citations
Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan
2008 • 351 citations
Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease
2008 • 324 citations
Renoprotective role of the vitamin D receptor in diabetic nephropathy
2007 • 296 citations
Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy
2007 • 293 citations
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
2008 • 285 citations
Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy
2006 • 283 citations
Retarding progression of chronic renal disease: The neglected issue of residual proteinuria
2003 • 268 citations
Suppression of renin–angiotensin gene expression in the kidney by paricalcitol
2008 • 262 citations
Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats
1998 • 248 citations
Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor–Mediated Sequestration of NF-κB Signaling
2008 • 247 citations
Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD
2006 • 224 citations
Combination Therapy with an Angiotensin-Converting Enzyme Inhibitor and a Vitamin D Analog Suppresses the Progression of Renal Insufficiency in Uremic Rats
2007 • 196 citations
Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial
2009 • 188 citations
Safety and efficacy of oral calcitriol (1, 25 -dihydroxyvitamin D3 ) for the treatment of psoriasis
1996 • 138 citations
Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial
2008 • 93 citations
Ratio of Paricalcitol Dosage to Serum Parathyroid Hormone Level and Survival in Maintenance Hemodialysis Patients
2008 • 63 citations
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria
2007 • 59 citations
Renal function during calcitriol therapy in chronic renal failure.
1990 • 54 citations
The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics
2009 • 38 citations
Role of Vitamin D in Blood Pressure Homeostasis
2010 • 28 citations